VIDAVO Stock Overview
Designs, develops, and provides connected health, wellness, and healthy ageing solutions. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Vidavo S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €2.58 |
| 52 Week High | €2.80 |
| 52 Week Low | €2.00 |
| Beta | 0.47 |
| 11 Month Change | 0% |
| 3 Month Change | 9.32% |
| 1 Year Change | -11.03% |
| 33 Year Change | -44.87% |
| 5 Year Change | -34.85% |
| Change since IPO | -21.10% |
Recent News & Updates
Shareholder Returns
| VIDAVO | GR Healthcare Services | GR Market | |
|---|---|---|---|
| 7D | 0% | -2.8% | -2.4% |
| 1Y | -11.0% | -11.6% | 8.6% |
Return vs Industry: VIDAVO matched the Greek Healthcare Services industry which returned -11.6% over the past year.
Return vs Market: VIDAVO underperformed the Greek Market which returned 8.6% over the past year.
Price Volatility
| VIDAVO volatility | |
|---|---|
| VIDAVO Average Weekly Movement | 3.6% |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in GR Market | 5.4% |
| 10% least volatile stocks in GR Market | 2.0% |
Stable Share Price: VIDAVO has not had significant price volatility in the past 3 months compared to the Greek market.
Volatility Over Time: VIDAVO's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 16 | Markella Psymarnou | www.vidavo.eu |
Vidavo S.A. designs, develops, and provides connected health, wellness, and healthy ageing solutions. The company offers Vida24, a cloud based platform and customizable app that synchs multi-source data. Its platform provides chronic disease management, doctor on demand, nutrition management, e-health and wellness, marine telemedicine, behavioral change, insuretech, corporate wellbeing, wearables, scientific wellness, and digital therapeutic solutions, as well as bouquet of ehealth and mhealth modules, health assessment, and mental health.
Vidavo S.A. Fundamentals Summary
| VIDAVO fundamental statistics | |
|---|---|
| Market cap | €2.21m |
| Earnings (TTM) | €194.29k |
| Revenue (TTM) | €1.43m |
11.4x
P/E Ratio1.5x
P/S RatioIs VIDAVO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VIDAVO income statement (TTM) | |
|---|---|
| Revenue | €1.43m |
| Cost of Revenue | €784.97k |
| Gross Profit | €643.06k |
| Other Expenses | €448.77k |
| Earnings | €194.29k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 45.03% |
| Net Profit Margin | 13.61% |
| Debt/Equity Ratio | 0% |
How did VIDAVO perform over the long term?
See historical performance and comparison